Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abdulelah A. Almutairdi
Observed names:
A Almutairdi,
A. Almutairdi,
Abdulelah AlMutairdi,
Abdulelah Almutairdi,
AlMutairdi A,
Almutairdi A
show all 6
Institutions:
Alfaisal University,
King Faisal Specialist Hospital & Research Centre
Observed institutions:
Alfaisal University,
University of Calgary,
Pontifícia Universidade Católica do Paraná,
King Abdulaziz University,
King Faisal Specialist Hospital & Research Centre,
King Saud Medical City,
King Saud University,
King Abdul Aziz University Hospital
show all 8
ORCID:
0009-0008-7000-2905
Observed ORCID:
0009-0008-7000-2905
OpenAlex ID:
A5066630652
Parenteral Nutrition and Lipids
2017
·
Maitreyi Raman
, Abdulelah Almutairdi
, et al.
·
Nutrients
·
148
PDF
Cross-Sectional Analysis of Overall Dietary Intake and Mediterranean Dietary Pattern in Patients with Crohn’s Disease
2018
·
Lorian Taylor
, Abdulelah Almutairdi
, et al.
·
Nutrients
·
85
PDF
Real‐world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
2018
·
Paulo G. Kotze
, Christopher Ma
, et al.
·
Alimentary Pharmacology & Therapeutics
·
61
Clinical utility of ustekinumab in Crohn’s disease
2018
·
Paulo Gustavo Kotze
, Christopher Ma
, et al.
·
Journal of Inflammation Research
·
41
PDF
Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab
2018
·
Christopher Ma
, Paulo G. Kotze
, et al.
·
Clinical Gastroenterology and Hepatology
·
30
Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
2023
·
Turki AlAmeel
, Abdulelah AlMutairdi
, et al.
·
Clinical and Experimental Gastroenterology
·
29
PDF
Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis
2019
·
C. Ma
, A. Almutairdi
, et al.
·
Colorectal Disease
·
21
Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis
2018
·
Paulo Gustavo Kotze
, Christopher Ma
, et al.
·
Therapeutic Advances in Gastroenterology
·
20
Upper gastrointestinal bleeding
2021
·
Majid A. Almadi
, Abdulelah Almutairdi
, et al.
·
Saudi Journal of Gastroenterology
·
16
Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis
2025
·
Wassel Sannaa
, Mazen Almasry
, et al.
·
Therapeutic Advances in Gastroenterology
·
12
Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
2023
·
Sameer Al Awadhi
, Mohamed Alboraie
, et al.
·
Journal of Clinical Medicine
·
9
PDF
Colorectal Neoplasia in Inflammatory Bowel Disease
2025
·
Eman Al Sulais
, Turki AlAmeel
, et al.
·
Cancers
·
4
PDF
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
2024
·
Omar I. Saadah
, Turki AlAmeel
, et al.
·
Saudi Journal of Gastroenterology
·
4
Prevalence and Impact of Zinc Deficiency on Clinical Outcomes in Inflammatory Bowel Disease
2025
·
Hend Almuhaya
, Raghad Alsalamah
, et al.
·
Nutrients
·
3
PDF
S4238 Ashwagandha’s Effects on the Gastrointestinal Tract: A Spectrum of Two Different Presentations
2024
·
Asma Alnajjar
, Muath Najmi
, et al.
·
The American Journal of Gastroenterology
·
2
A115 Clinical, Radiographic, and Endoscopic Remission With Vedolizumab Treatment in Crohn’s Disease
2018
·
P Kotze
, C Ma
, et al.
·
Journal of the Canadian Association of Gastroenterology
·
2
PDF
P634 Clinical and endoscopic remission with vedolizumab treatment in ulcerative colitis
2018
·
A Almutairdi
, C Ma
, et al.
·
Journal of Crohn s and Colitis
·
2
PDF
P367 Vedolizumab and early postoperative complications in non-intestinal surgery: A case-matched analysis
2018
·
P G Kotze
, N Mckenna
, et al.
·
Journal of Crohn s and Colitis
·
2
PDF
DOP039 Exploring stoma rates in Crohn’s disease in the biologic era: a population-based time trend analysis
2018
·
C Ma
, P G Kotze
, et al.
·
Journal of Crohn s and Colitis
·
2
PDF
Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease
2026
·
Julian Azar
, Rofina Johnkennedy
, et al.
·
Therapeutic Advances in Gastroenterology
·
1
Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease
2025
·
Mahmoud H. Mosli
, Badr Al-Bawardy
, et al.
·
Saudi Journal of Gastroenterology
·
1
S1498 Prevalence and Outcomes of Active and Latent Tuberculosis Among Patients With Inflammatory Bowel Disease (IBD) in an Endemic Region
2024
·
Mohammed Alayed
, Abdulrahman Alrasheed
, et al.
·
The American Journal of Gastroenterology
·
1
Inflammatory bowel disease training assessment of gastroenterology fellows in Saudi Arabia
2024
·
Hassan AlDhneem
, Abdulelah AlMutairdi
, et al.
·
Saudi Journal of Gastroenterology
·
1
Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy
2023
·
Nahla A. Azzam
, Abdulelah Almutairdi
, et al.
·
Saudi Journal of Gastroenterology
·
1
Sa1692 - Vedolizumab and Early Postoperative Complications in Nonintestinal Surgery: A Case-Matched Analysis
2018
·
Abdulelah A. Almutairdi
, Paulo G. Kotze
, et al.
·
Gastroenterology
·
1
Show more works
View as search
Works count:
51
Citation count:
500
H-index:
10
I10-index:
10
Year
Topic
Type